Startups · AI

Director, Regulatory

Hippocratic AI · Menlo Park, CA · On-site

← All jobs
About Hippocratic AI

Hippocratic AI builds the safest generative AI healthcare agent for health systems, payors, and pharma. Over 180 million clinical interactions across 1,000+ use cases with 60+ partners worldwide. Backed by General Catalyst, Kleiner Perkins and a16z.

About the role

Define and maintain Regulatory standards that govern the platform's patient-facing and HCP-facing interactions. Establish labelling operations frameworks for l delivery, ensuring responses are accurate, evidence-based, and aligned with approved labeling and non-promotional requirements.

What they're looking for

  • Required
  • 7–15 years of experience in regulatory operations regulatory affairs, within pharma, biotech, or life sciences services organizations
  • Deep working knowledge of MLR review processes, non-promotional communication standards, and medical information operations and adverse event reporting, pharmacovigilance regulations,
  • Strong understanding of FDA and EMA regulatory frameworks as they apply to patient engagement, medical communications, and digital health technologies
  • Demonstrated ability to engage credibly with VP, SVP, and C-suite stakeholders across medical, regulatory, legal, and compliance functions at pharma organizations
  • Experience translating regulatory and medical requirements into operational workflows, product requirements, or technology specifications
More about this role

Hippocratic AI is the leading generative AI company in healthcare. We have the only system that can have safe, autonomous, clinical conversations with patients. We have trained our own LLMs as part of our Polaris constellation, resulting in a system with over 99.9% accuracy.

Hippocratic AI is rapidly expanding across the pharma and medtech industries. We are building a new class of agentic AI that supports patients and healthcare stakeholders across the entire life sciences value chain including patient services, clinical trials, access, adherence, and HCP-facing workflows. We are contracted with 5 of the top 20 pharma globally and are in a hyper growth phase for our Life Sciences vertical.

Backed by the world’s leading Life Science and AI investors. We recently raised a $126M Series C at a $3.5B valuation, led by Avenir Growth, bringing total funding to $404M with participation from CapitalG, General Catalyst, a16z, Kleiner Perkins, Premji Invest, UHS, Cincinnati Children’s, WellSpan Health, John Doerr, Rick Klausner, and others.

The Head of Regulatory is responsible for ensuring Hippocratic AI's life sciences platform meets the scientific, medical, and regulatory standards...

Read the full posting on Hippocratic AI's site ↗

Research & Development

Build your edge while you search

Free tools for founders and investors, plus VC Unfiltered, our take on startups, venture and the people who build them.